Condition: Penetrating Ulcer of Aorta · Aneurysm Aortic · Type B Aortic Dissection · Sponsor: Ceric Sàrl
The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft. Clinical utility measures throughout the procedure and until discharge will be assessed
This description comes directly from the study's public registry record.
Laure Morsiani, PhD · +33.1.76.73.92.36 · contact@cerc-europe.org
Always discuss trial participation with your own doctor first.
| CH de Brest | Brest, France | Recruiting |
| Hôpital Louis Pradel | Bron, France | Not Yet Recruiting |
| CHU de Montpellier | Montpellier, France | Recruiting |
| CH d'Orléans | Orléans, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05479305